Retinopathy of Prematurity
Retinopathy of prematurity is an eye disease that occurs in babies born prematurely. It causes abnormal blood vessels to grow in the retina and can lead to blindness in severe cases.
Quick Answer
What it is
Retinopathy of prematurity is an eye disease that occurs in babies born prematurely. It causes abnormal blood vessels to grow in the retina and can lead to blindness in severe cases.
Key findings
No graded findings are available yet.
Safety
No specific caution or interaction language was detected in the current summary/outcome notes.
ℹ️ Quick Facts
Quick Facts: Retinopathy of Prematurity
- Supplements Studied:0
Evidence-Based Protocol
Supplement stack ranked by research quality
Primary Stack (Tier 1)
DHA essential for retinal development; premature infants miss third-trimester DHA transfer; may reduce ROP risk
Antioxidant; protects retinal tissue from oxidative damage; studied for ROP prevention
Supporting Stack (Tier 2)
Essential for eye development and function; premature infants often deficient
Cell signaling molecule important for lung and eye development; studied for ROP prevention
Macular pigments that protect retina from oxidative damage; naturally transferred in breast milk
Essential for retinal function and vitamin A metabolism; premature infants at risk of deficiency
Given for apnea of prematurity; incidentally reduces ROP risk through unknown mechanisms
How It Works
Retinopathy of Prematurity (ROP) is an eye disease that affects premature babies, particularly those born before 31 weeks or weighing less than 1500 grams. In the womb, retinal blood vessels normally develop and reach the edge of the retina by about 36-40 weeks. When a baby is born prematurely, this development is incomplete. The abnormal blood vessel growth that follows can cause scarring, retinal detachment, and potentially blindness.
CRITICAL: ROP is a serious condition that requires expert NICU and ophthalmologic care. All at-risk premature infants receive regular eye examinations. Treatment when needed includes laser therapy, injections (anti-VEGF), or surgery. The supplements listed here are administered under strict medical supervision in the NICU setting and are NOT for home use. This information is for educational purposes about current research.
RISK FACTORS: Very low birth weight (<1500g), gestational age <31 weeks, supplemental oxygen exposure, sepsis, blood transfusions, respiratory distress syndrome, and other complications of prematurity.
* DHA (Omega-3) is critical for retinal development. Premature infants miss the third-trimester transfer of DHA from mother to baby. Supplementation in enteral feeds may help reduce ROP risk.
* Vitamin E is an antioxidant that may protect the developing retina from oxygen-related damage. Must be carefully dosed as high levels can be harmful.
* Vitamin A is essential for eye development and is often deficient in premature infants.
* Inositol is a naturally occurring compound important for surfactant function and eye development.
* Lutein/Zeaxanthin are macular pigments that protect the retina. They are naturally present in breast milk.
* Caffeine is routinely given for apnea of prematurity and has been found to incidentally reduce ROP risk.
Expected outcomes: ROP screening and treatment have dramatically improved outcomes. Most mild ROP resolves without treatment. With appropriate care, severe visual impairment from ROP has decreased significantly.